101
|
Thomas TC, Grandy DK, Gerhardt GA, Glaser PEA. Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum. Neuropsychopharmacology 2009; 34:436-45. [PMID: 18536704 PMCID: PMC7223095 DOI: 10.1038/npp.2008.74] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
To better understand the effect of the dopamine D4 receptor (DRD4) on glutamate (Glu) neurotransmission in the brain, we utilized transgenic mice with partial or complete removal of functional DRD4 plasma membrane expression (DRD4+/- and DRD4-/-, respectively). We measured resting extracellular Glu levels, Glu clearance kinetics, and KCl-evoked release of Glu in the striatum and nucleus accumbens core of these mice using in vivo amperometry coupled to a novel microelectrode array configured for sub-second detection of Glu. Recordings from DRD4-/- and DRD4+/- mice were compared with their wild-type littermates (DRD4+/+). Resting extracellular levels of Glu were increased in the striatum of DRD4-/- mice (p<0.01). Glu clearance kinetics were significantly decreased in the dorsal striatum of DRD4-/- mice (p<0.05). KCl-evoked overflow of Glu was reliably measured but unchanged in the striatum of the three groups. By contrast, no changes in resting Glu, Glu uptake kinetics, or KCl-evoked release of Glu were observed in the nucleus accumbens core among the three genotypes. These data indicate that the DRD4 receptor is involved in modulation of Glu neurotransmission, primarily in the striatum. A better understanding of Glu control by the DRD4 may improve our understanding of the physiological role of the DRD4 in disorders such as attention-deficit/hyperactivity disorder and schizophrenia.
Collapse
Affiliation(s)
- Theresa Currier Thomas
- Department of Anatomy & Neurobiology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Center for Microelectrode Technology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Morris K Udall Parkinson’s Disease Research Center of Excellence, University of Kentucky Chandler Medical Center, Lexington, KY, USA
| | - David K Grandy
- Department of Physiology, Oregon Health and Science University, Portland, OR, USA,Department of Pharmacology, Oregon Health and Science University, Portland, OR, USA
| | - Greg A Gerhardt
- Department of Anatomy & Neurobiology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Center for Microelectrode Technology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Morris K Udall Parkinson’s Disease Research Center of Excellence, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Department of Psychiatry, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Department of Neurology, University of Kentucky Chandler Medical Center, Lexington, KY, USA
| | - Paul EA Glaser
- Department of Anatomy & Neurobiology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Center for Microelectrode Technology, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Morris K Udall Parkinson’s Disease Research Center of Excellence, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Department of Psychiatry, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Department of Pediatrics, University of Kentucky Chandler Medical Center, Lexington, KY, USA,Correspondence: Dr PEA Glaser, Department of Psychiatry, University of Kentucky, 306 Whitney-Hendrickson Facility, 800 Rose Street, Lexington, KY 40536-0098, USA, Tel: + 1 859 323 4531, Fax: + 1 859 257 5310,
| |
Collapse
|
102
|
Microsensors for in vivo Measurement of Glutamate in Brain Tissue. SENSORS 2008; 8:6860-6884. [PMID: 27873904 PMCID: PMC3787420 DOI: 10.3390/s8116860] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/08/2008] [Revised: 10/24/2008] [Accepted: 11/03/2008] [Indexed: 12/31/2022]
Abstract
Several immobilized enzyme-based electrochemical biosensors for glutamate detection have been developed over the last decade. In this review, we compare first and second generation sensors. Structures, working mechanisms, interference prevention, in vitro detection characteristics and in vivo performance are summarized here for those sensors that have successfully detected brain glutamate in vivo. In brief, first generation sensors have a simpler structure and are faster in glutamate detection. They also show a better sensitivity to glutamate during calibration in vitro. For second generation sensors, besides their less precise detection, their fabrication is difficult to reproduce, even with a semi-automatic dip-coater. Both generations of sensors can detect glutamate levels in vivo, but the reported basal levels are different. In general, second generation sensors detect higher basal levels of glutamate compared with the results obtained from first generation sensors. However, whether the detected glutamate is indeed from synaptic sources is an issue that needs further attention.
Collapse
|
103
|
Ainslie KM, Desai TA. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. LAB ON A CHIP 2008; 8:1864-78. [PMID: 18941687 PMCID: PMC2970504 DOI: 10.1039/b806446f] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
By adapting microfabrication techniques originally developed in the microelectronics industry novel devices for drug delivery, tissue engineering and biosensing have been engineered for in vivo use. Implant microfabrication uses a broad range of techniques including photolithography, and micromachining to create devices with features ranging from 0.1 to hundreds of microns with high aspect ratios and precise features. Microfabrication offers device feature scale that is relevant to the tissues and cells to which they are applied, as well as offering ease of en masse fabrication, small device size, and facile incorporation of integrated circuit technology. Utilizing these methods, drug delivery applications have been developed for in vivo use through many delivery routes including intravenous, oral, and transdermal. Additionally, novel microfabricated tissue engineering approaches propose therapies for the cardiovascular, orthopedic, and ocular systems, among others. Biosensing devices have been designed to detect a variety of analytes and conditions in vivo through both enzymatic-electrochemical reactions and sensor displacement through mechanical loading. Overall, the impact of microfabricated devices has had an impact over a broad range of therapies and tissues. This review addresses many of these devices and highlights their fabrication as well as discusses materials relevant to microfabrication techniques.
Collapse
Affiliation(s)
- Kristy M. Ainslie
- Department of Bioengineering and Therapeutic Sciences; Department of Physiology University of California, San Francisco
| | - Tejal A. Desai
- Department of Bioengineering and Therapeutic Sciences; Department of Physiology University of California, San Francisco
| |
Collapse
|
104
|
Wassum KM, Tolosa VM, Wang J, Walker E, Monbouquette HG, Maidment NT. Silicon Wafer-Based Platinum Microelectrode Array Biosensor for Near Real-Time Measurement of Glutamate in Vivo. SENSORS 2008; 8:5023-5036. [PMID: 19543440 PMCID: PMC2699285 DOI: 10.3390/s8085023] [Citation(s) in RCA: 110] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Using Micro-Electro-Mechanical-Systems (MEMS) technologies, we have developed silicon wafer-based platinum microelectrode arrays (MEAs) modified with glutamate oxidase (GluOx) for electroenzymatic detection of glutamate in vivo. These MEAs were designed to have optimal spatial resolution for in vivo recordings. Selective detection of glutamate in the presence of the electroactive interferents, dopamine and ascorbic acid, was attained by deposition of polypyrrole and Nafion. The sensors responded to glutamate with a limit of detection under 1muM and a sub-1-second response time in solution. In addition to extensive in vitro characterization, the utility of these MEA glutamate biosensors was also established in vivo. In the anesthetized rat, these MEA glutamate biosensors were used for detection of cortically-evoked glutamate release in the ventral striatum. The MEA biosensors also were applied to the detection of stress-induced glutamate release in the dorsal striatum of the freely-moving rat.
Collapse
Affiliation(s)
- Kate M. Wassum
- Dept. Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA; E-mails: (K.M.W.); (E.W.)
- Authors to whom correspondence should be addressed; E-mails: (H.G.M.); (N.T.M); Tel.: +1-310-206-7767; Fax: +1-310-825-7067
| | - Vanessa M. Tolosa
- Dept. Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA; E-mails: (K.M.W.); (E.W.)
| | - Jianjun Wang
- Chemical and Biomolecular Engineering Dept., UCLA, Los Angeles, CA, USA; E-Mails: (V.M.T.); (J.W.)
| | - Eric Walker
- Dept. Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA; E-mails: (K.M.W.); (E.W.)
| | - Harold G. Monbouquette
- Chemical and Biomolecular Engineering Dept., UCLA, Los Angeles, CA, USA; E-Mails: (V.M.T.); (J.W.)
- Authors to whom correspondence should be addressed; E-mails: (H.G.M.); (N.T.M); Tel.: +1-310-206-7767; Fax: +1-310-825-7067
| | - Nigel T. Maidment
- Dept. Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA; E-mails: (K.M.W.); (E.W.)
- Authors to whom correspondence should be addressed; E-mails: (H.G.M.); (N.T.M); Tel.: +1-310-206-7767; Fax: +1-310-825-7067
| |
Collapse
|
105
|
Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci 2008; 28:3769-80. [PMID: 18385335 DOI: 10.1523/jneurosci.5251-07.2008] [Citation(s) in RCA: 106] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Because modulation of cortical cholinergic neurotransmission has been hypothesized to represent a necessary mechanism mediating the beneficial cognitive effects of nicotine and nicotinic acetylcholine receptor (nAChR) subtype-selective agonists, we used choline-sensitive microelectrodes for the real-time measurement of ACh release in vivo, to characterize cholinergic transients evoked by nicotine and the alpha4beta2*-selective nAChR partial agonist 2-methyl-3-(2-(S)-pyrrolindinylmethoxy)pyridine dihydrochloride (ABT-089), a clinically effective cognition enhancer. In terms of cholinergic signal amplitudes, ABT-089 was significantly more potent than nicotine in evoking ACh cholinergic transients. Moreover, cholinergic signals evoked by ABT-089 were characterized by faster signal rise time and decay rate. The nAChR antagonist mecamylamine attenuated the cholinergic signals evoked by either compound. Cholinergic signals evoked by ABT-089 were more efficaciously attenuated by the relatively beta2*-selective nAChR antagonist dihydro-beta-erythroidine. The alpha7 antagonist methyllycaconitine did not affect choline signal amplitudes but partly attenuated the relatively slow decay rate of nicotine-evoked cholinergic signals. Furthermore, the AMPA receptor antagonist DNQX as well as the NMDA receptor antagonist APV more potently attenuated cholinergic signals evoked by ABT-089. Using glutamate-sensitive microelectrodes to measure glutamatergic transients, ABT-089 was more potent than nicotine in evoking glutamate release. Glutamatergic signals were highly sensitive to tetrodotoxin-induced blockade of voltage-regulated sodium channels. Together, the present evidence indicates that compared with nicotine, ABT-089 evokes more potent and sharper cholinergic transients in prefrontal cortex. Glutamatergic mechanisms necessarily mediate the cholinergic effects of nAChR agonists in the prefrontal cortex.
Collapse
|
106
|
Zakir Hossain SM, Shinohara H, Kitano H. Drug assessment based on detection of L-glutamate released from C6 glioma cells using an enzyme-luminescence method. Anal Chem 2008; 80:3762-8. [PMID: 18399661 DOI: 10.1021/ac702392p] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Monitoring of excitation activity of nerve cells is very useful for not only brain research but also assessment of the effects of various chemicals, including drugs and toxins. We previously reported a novel enzyme-luminescence method for real-time monitoring of l-glutamate release from C6 glioma cells with high levels of sensitivity ( approximately 10 nM) and temporal resolution (<1 s) using a luminescence plate reader. In the present study, we tested the applicability of this novel system for assessment of effects of drugs in vitro. Several drugs (e.g., veratridine and 4-aminopyridine) were administered to C6 glioma cells for inducing glutamate release. Moreover, antagonists of voltage-dependent Ca (2+) channels (e.g., nifedipine, flunarizine, and NiCl 2) and Na (+) channels (e.g., carbamazepine and lidocaine) were applied separately for evaluating the effects of these chemicals on glutamate release from the cells. The combined effect of carbamazepine and lidocaine was also investigated by using our method, and the combined effect was found to be more potent than that of single drug administration. These results indicated that the glutamate release from C6 cells was modulated by these drugs in a way similar to that found by using several conventional analytical techniques. We therefore conclude that the developed monitoring system for real-time detection of dynamic l-glutamate release from cells could be very useful for application to assessment of drugs acting on the nervous system.
Collapse
Affiliation(s)
- S M Zakir Hossain
- Course of Advanced Nano and Biosciences, Graduate School of Innovative Life Science for Education, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan.
| | | | | |
Collapse
|
107
|
Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA. Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 2008; 324:725-31. [PMID: 18024788 PMCID: PMC3404456 DOI: 10.1124/jpet.107.131698] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
l-Glutamate (Glu) is the main excitatory neurotransmitter in the mammalian central nervous system, and it is involved in most aspects of normal brain function, including cognition, memory and learning, plasticity, and motor movement. Although microdialysis techniques have been used to study Glu, the slow temporal resolution of the technique may be inadequate to properly examine tonic and phasic Glu. Thus, our laboratory has developed an enzyme-based microelectrode array (MEA) with fast response time and low detection limits for Glu. We have modified the MEA design to allow for reliable measures in the brain of awake, freely moving mice. In this study, we chronically implanted the MEA in prefrontal cortex (PFC) or striatum (Str) of awake, freely moving C57BL/6 mice. We successfully measured Glu levels 7 days postimplantation without loss of MEA sensitivity. In addition, we determined resting (tonic) Glu levels to be 3.3 microM in the PFC and 5.0 microM in the Str. Resting Glu levels were subjected to pharmacological manipulation with tetrodotoxin (TTX) and dl-threo-beta-hydroxyaspartate (THA). TTX significantly (p < 0.05) decreased resting Glu by 20%, whereas THA significantly (p < 0.05) increased resting Glu by 60%. Taken together, our data show that chronic recordings of tonic and phasic clearance of exogenously applied Glu can be carried out in awake mice for at least 7 days in vivo, allowing for longer term studies of Glu regulation.
Collapse
Affiliation(s)
- K N Hascup
- Department of Anatomy and Neurobiology, 306 Whitney-Hendrickson Facility, 800 Rose St., Lexington, KY 40536-0098, USA
| | | | | | | | | |
Collapse
|
108
|
Pernot P, Mothet JP, Schuvailo O, Soldatkin A, Pollegioni L, Pilone M, Adeline MT, Cespuglio R, Marinesco S. Characterization of a Yeast d-Amino Acid Oxidase Microbiosensor for d-Serine Detection in the Central Nervous System. Anal Chem 2008; 80:1589-97. [DOI: 10.1021/ac702230w] [Citation(s) in RCA: 84] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Pierre Pernot
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Jean-Pierre Mothet
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Oleg Schuvailo
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Alexey Soldatkin
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Loredano Pollegioni
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Mirella Pilone
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Marie-Thérèse Adeline
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Raymond Cespuglio
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| | - Stéphane Marinesco
- CNRS, Institut de Neurobiologie Alfred FessardFRC2118, Laboratoire de Neurobiologie Cellulaire et MoléculaireUPR9040, 91198 Gif sur Yvette, France, Institut National de la Santé et de la Recherche Médicale U862, Université Bordeaux 2, Institut Magendie, 146 rue Léo Saignat, 33077 Bordeaux, France, EA4170, Université Claude Bernard Lyon I, 8 avenue Rockefeller, 69373 Lyon, France, Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, 150 zabolotny Str, 03143 Kiev, Ukraine,
| |
Collapse
|
109
|
Abstract
The theoretical groundwork of the 1930s and 1940s and the technical advance of computers in the following decades provided the basis for dramatic increases in human efficiency. While computers continue to evolve, and we can still expect increasing benefits from their use, the interface between humans and computers has begun to present a serious impediment to full realization of the potential payoff. This paper is about the theoretical and practical possibility that direct communication between the brain and the computer can be used to overcome this impediment by improving or augmenting conventional forms of human communication. It is about the opportunity that the limitations of our body's input and output capacities can be overcome using direct interaction with the brain, and it discusses the assumptions, possible limitations and implications of a technology that I anticipate will be a major source of pervasive changes in the coming decades.
Collapse
Affiliation(s)
- Gerwin Schalk
- Brain-Computer Interface Research and Development Program, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
| |
Collapse
|
110
|
Gerhardt GA, Tresco PA. Sensor Technology. BRAIN-COMPUTER INTERFACES 2008. [DOI: 10.1007/978-1-4020-8705-9_2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
111
|
Barbosa RM, Lourenço CF, Santos RM, Pomerleau F, Huettl P, Gerhardt GA, Laranjinha J. In Vivo Real‐Time Measurement of Nitric Oxide in Anesthetized Rat Brain. Methods Enzymol 2008; 441:351-67. [DOI: 10.1016/s0076-6879(08)01220-2] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
112
|
Berger TW, Gerhardt G, Liker MA, Soussou W. The Impact of Neurotechnology on Rehabilitation. IEEE Rev Biomed Eng 2008; 1:157-97. [PMID: 22274903 DOI: 10.1109/rbme.2008.2008687] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Theodore W Berger
- Department of Biomedical Engineering, Center for Neural Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA
| | | | | | | |
Collapse
|
113
|
Rutherford EC, Pomerleau F, Huettl P, Strömberg I, Gerhardt GA. Chronic second-by-second measures of L-glutamate in the central nervous system of freely moving rats. J Neurochem 2007; 102:712-22. [PMID: 17630982 PMCID: PMC3482110 DOI: 10.1111/j.1471-4159.2007.04596.x] [Citation(s) in RCA: 97] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
l-glutamate (Glu) is the main excitatory neurotransmitter in the central nervous system (CNS) and is associated with motor behavior and sensory perception. While microdialysis methods have been used to record tonic levels of Glu, little is known about the more rapid changes in Glu signals that may be observed in awake rats. We have reported acute recording methods using enzyme-based microelectrode arrays (MEA) with fast response time and low detection levels of Glu in anesthetized animals with minimal interference. The current paper concerns modification of the MEA design to allow for reliable measures in the brain of conscious rats. In this study, we characterized the effects of chronic implantation of the MEA into the brains of rats. We were capable of measuring Glu levels for 7 days without loss of sensitivity. We performed studies of tail-pinch induced stress, which caused a robust biphasic increase in Glu. Histological data show chronic implantation of the MEAs caused minimal injury to the CNS. Taken together, our data show that chronic recordings of tonic and phasic Glu can be carried out in awake rats for up to 17 days in vivo allowing longer term studies of Glu regulation in behaving rats.
Collapse
Affiliation(s)
- Erin C. Rutherford
- Anatomy and Neurobiology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, Center for Sensor Technology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
| | - Francois Pomerleau
- Anatomy and Neurobiology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, Center for Sensor Technology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
| | - Peter Huettl
- Anatomy and Neurobiology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, Center for Sensor Technology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
| | - Ingrid Strömberg
- Department of Integrative Medical Biology, Umeå University, Umeå, Sweden
| | - Greg A. Gerhardt
- Anatomy and Neurobiology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, Center for Sensor Technology, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
| |
Collapse
|
114
|
Zakir Hossain SM, Shinohara H, Wang F, Kitano H. Real-time detection of L-glutamate released from C6 glioma cells using a modified enzyme-luminescence method. Anal Bioanal Chem 2007; 389:1961-6. [PMID: 17849100 DOI: 10.1007/s00216-007-1569-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2007] [Revised: 08/07/2007] [Accepted: 08/20/2007] [Indexed: 11/26/2022]
Abstract
There is an increasing interest in new strategies to detect neurotransmitters released from nerve cells in real time for brain science, drug assessment, and so on. Previously we reported real-time monitoring of dopamine release from nerve model cells by enzyme-catalyzed luminescence measurement with tyramine oxidase and peroxidase. In the present study, the system was modified with glutamate oxidase instead of tyramine oxidase to detect L-glutamate sensitively ( approximately 10 nM) and rapidly with high temporal resolution (<1 s). We applied this modified method successfully to perform real-time monitoring of L-glutamate release from brain model cell (C6 glioma cell) using a luminescence plate reader upon stimulation with high concentration of KCl (>10 mM) or 5-hydroxytryptamine (>1 microM). The measurement solution was not toxic and therefore the L-glutamate release from the cell was measured by the second stimulation after exchanging the measurement solution. We conclude that the developed monitoring system is suitable for real-time detection of dynamic L-glutamate release from nerve cells in vitro and will be suitable for application in assessment of drugs acting on the nervous system.
Collapse
Affiliation(s)
- S M Zakir Hossain
- Department of Advanced Nano and Biosciences, Graduate School of Innovative Life Science, University of Toyama, 3190 Gofuku, Toyama 930-8555. Japan.
| | | | | | | |
Collapse
|
115
|
Quintero JE, Day BK, Zhang Z, Grondin R, Stephens ML, Huettl P, Pomerleau F, Gash DM, Gerhardt GA. Amperometric measures of age-related changes in glutamate regulation in the cortex of rhesus monkeys. Exp Neurol 2007; 208:238-46. [PMID: 17927982 DOI: 10.1016/j.expneurol.2007.08.002] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2007] [Revised: 08/01/2007] [Accepted: 08/07/2007] [Indexed: 11/17/2022]
Abstract
l-glutamate (glutamate) is the principal excitatory neurotransmitter of the central nervous system and is involved in altered neural function during aging and in neurodegenerative diseases. Relatively little is known about the mechanisms of glutamate signaling in the primate brain, in part, because there is an absence of a method capable of rapidly measuring glutamate in either a non-clinical or a clinical setting. We have addressed this paucity of information by measuring extracellular glutamate at 1 Hz in the pre-motor and motor cortices of young, middle-aged, and aged monkeys using a minimally invasive amperometric recording method. In the motor cortex, mean resting glutamate levels were five times higher in the aged group compared to the young group while the pre-motor cortex showed an increasing trend in resting glutamate levels that was not statistically significant. In addition, we measured rapid, phasic glutamate release after local pressure-ejection of nanoliter volumes of either isotonic 70 mM potassium (to stimulate glutamate release) or 1 mM glutamate (to study glutamate uptake) into the pre-motor and motor cortex. In the pre-motor cortex, we measured reproducible glutamate uptake signals that had a significantly decreased (47%) rate of glutamate uptake in aged animals compared to young animals. However, following a 70 mM potassium delivery, we did not observe any consistent changes in evoked release between young versus aged animals. Using these non-clinical microelectrodes to measure glutamate signaling in the brain, our results support the hypothesis that the glutamatergic system undergoes reorganization with aging of the central nervous system.
Collapse
Affiliation(s)
- Jorge E Quintero
- Department of Anatomy and Neurobiology, University of Kentucky, Lexington, KY 40536-0098, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
116
|
Li XH, Xian YZ, Xie ZH, Min H, Li CX, Jin LT. Amperometric Sensor Based on Neutral Red-Doped Silica Nanoparticles Coupled with Microdialysis for the Measurement of Glutamate in the Rat Striatum. CHINESE J CHEM 2007. [DOI: 10.1002/cjoc.200790185] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
117
|
Sarter M, Bruno JP, Parikh V. Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology 2007; 32:1452-61. [PMID: 17164812 DOI: 10.1038/sj.npp.1301285] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Abnormalities in the regulation of neurotransmitter release and/or abnormal levels of extracellular neurotransmitter concentrations have remained core components of hypotheses on the neuronal foundations of behavioral and cognitive disorders and the symptoms of neuropsychiatric and neurodegenerative disorders. Furthermore, therapeutic drugs for the treatment of these disorders have been developed and categorized largely on the basis of their effects on neurotransmitter release and resulting receptor stimulation. This perspective stresses the theoretical and practical implications of hypotheses that address the dynamic nature of neurotransmitter dysregulation, including the multiple feedback mechanisms regulating synaptic processes, phasic and tonic components of neurotransmission, compartmentalized release, differentiation between dysregulation of basal vs activated release, and abnormal release from neuronal systems recruited by behavioral and cognitive activity. Several examples illustrate that the nature of the neurotransmitter dysregulation in animal models, including the direction of drug effects on neurotransmitter release, depends fundamentally on the state of activity of the neurotransmitter system of interest and on the behavioral and cognitive functions recruiting these systems. Evidence from evolving techniques for the measurement of neurotransmitter release at high spatial and temporal resolution is likely to advance hypotheses describing the pivotal role of neurotransmitter dysfunction in the development of essential symptoms of major neuropsychiatric disorders, and also to refine neuropharmacological mechanisms to serve as targets for new treatment approaches. The significance and usefulness of hypotheses concerning the abnormal regulation of the release of extracellular concentrations of primary messengers depend on the effective integration of emerging concepts describing the dynamic, compartmentalized, and activity-dependent characteristics of dysregulated neurotransmitter systems.
Collapse
Affiliation(s)
- Martin Sarter
- Department of Psychology, University of Michigan, Ann Arbor, MI 48109-1043, USA.
| | | | | |
Collapse
|
118
|
Burmeister JJ, Coates TD, Gerhardt GA. Multisite microelectrode arrays for measurements of multiple neurochemicals. CONFERENCE PROCEEDINGS : ... ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL CONFERENCE 2007; 2004:5348-51. [PMID: 17271550 DOI: 10.1109/iembs.2004.1404493] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Multisite microelectrode arrays designed for electrochemical measures of neurochemicals in CNS tissues are presented. The arrays have platinum recording sites insulated with polyimide on a ceramic substrate. Most designs include 4 recording sites, however arrays with 5 to 8 recording sites have been fabricated. Enzyme coatings have been developed to measure glutamate, choline, lactate, and glucose. Electroactive compounds such as dopamine, norepinephrine, and O/sub 2/ can also be measured. The multiple recording sites can be exploited for interferent or noise removal and measures of multiple compounds using a single microelectrode array.
Collapse
Affiliation(s)
- J J Burmeister
- Morris K. Udall Parkinson's Disease Research Center of Excellence, Kentucky University, Lexington, KY, USA
| | | | | |
Collapse
|
119
|
McMahon CP, Rocchitta G, Serra PA, Kirwan SM, Lowry JP, O'Neill RD. Control of the oxygen dependence of an implantable polymer/enzyme composite biosensor for glutamate. Anal Chem 2007; 78:2352-9. [PMID: 16579619 DOI: 10.1021/ac0518194] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Biosensors for glutamate (Glu) were fabricated from Teflon-coated Pt wire (cylinders and disks), modified with the enzyme glutamate oxidase (GluOx) and electrosynthesized polymer PPD, poly(o-phenylenediamine). The polymer/enzyme layer was deposited in two configurations: enzyme before polymer (GluOx/PPD) and enzyme after polymer (PPD/GluOx). These four biosensor designs were characterized in terms of response time, limit of detection, Michaelis-Menten parameters for Glu (J max and K(M)(Glu)), sensitivity to Glu in the linear response region, and dependence on oxygen concentration, K(M)(O2). Analysis showed that the two polymer/enzyme configurations behaved similarly on both cylinders and disks. Although the two geometries showed different behaviors, these differences could be explained in terms of higher enzyme loading density on the disks; in many analyses, the four designs behaved like a single population with a range of GluOx loading. Enzyme loading was the key to controlling the K(M)(O2) values of these first generation biosensors. The counterintuitive, and beneficial, behavior that biosensors with higher GluOx loading displayed a lower oxygen dependence was explained in terms of the effects of enzyme loading on the affinity of GluOx for its anionic substrate. Some differences between the properties of surface immobilized GluOx and glucose oxidase are highlighted.
Collapse
Affiliation(s)
- Colm P McMahon
- UCD School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland
| | | | | | | | | | | |
Collapse
|
120
|
Oldenziel WH, Dijkstra G, Cremers TIFH, Westerink BHC. Evaluation of hydrogel-coated glutamate microsensors. Anal Chem 2007; 78:3366-78. [PMID: 16689539 DOI: 10.1021/ac052146s] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Glutamate microsensors form a promising analytical tool for monitoring neuronally derived glutamate directly in the brain. However, when a microsensor is implanted in brain tissue, many factors can diminish its performance. Consequently, a thorough characterization and evaluation of a microsensor is required concerning all factors that may possibly be encountered in vivo. The present report deals with the validation of a hydrogel-coated glutamate microsensor. This microsensor is constructed by coating a carbon fiber electrode (10-microm diameter; 300-500 microm long) with a five-component redox hydrogel, in which L-glutamate oxidase, horseradish peroxidase, and ascorbate oxidase are wired via poly(ethylene glycol) diglycidyl ether to an osmium-containing redox polymer. A thin Nafion coating completes the construction. Although this microsensor was previously used in vivo, information concerning its validation is limited. In the present study, attention was given to its selectivity, specificity, calibration, oxygen dependency, biofouling, operating potential dependency, and linear range. In addition, successful microsensor experiments in microdialysate, in vitro (in organotypic hippocampal slice cultures), and in vivo (in anesthesized rats) are shown.
Collapse
Affiliation(s)
- Weite H Oldenziel
- Department of Biomonitoring and Sensoring, University Center for Pharmacy, Groningen, The Netherlands.
| | | | | | | |
Collapse
|
121
|
Walker E, Wang J, Hamdi N, Monbouquette HG, Maidment NT. Selective detection of extracellular glutamate in brain tissue using microelectrode arrays coated with over-oxidized polypyrrole. Analyst 2007; 132:1107-11. [DOI: 10.1039/b706880h] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
122
|
Bruno JP, Gash C, Martin B, Zmarowski A, Pomerleau F, Burmeister J, Huettl P, Gerhardt GA. Second-by-second measurement of acetylcholine release in prefrontal cortex. Eur J Neurosci 2006; 24:2749-57. [PMID: 17156201 DOI: 10.1111/j.1460-9568.2006.05176.x] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Microdialysis has been widely used to measure acetylcholine (ACh) release in vivo and has provided important insights into the regulation of cholinergic transmission. However, microdialysis can be constrained by limited spatial and temporal resolution. The present experiments utilize a microelectrode array (MEA) to rapidly measure ACh release and clearance in anaesthetized rats. The array electrochemically detects, on a second-by-second basis, changes in current selectively produced by the hydrolysis of ACh to choline (Ch) and the subsequent oxidation of choline and hydrogen peroxidase (H(2)O(2)) at the electrode surface. In vitro calibration of the microelectrode revealed linear responses to ACh (R(2) = 0.9998), limit of detection of 0.08 microm, and signal-to-noise ratio of 3.0. The electrode was unresponsive to ascorbic acid (AA), dopamine (DA), or norepinephrine (NE) interferents. In vivo experiments were conducted in prefrontal cortex (PFC) of anaesthetized rats. Pressure ejections of ACh (10 mm; 40 nL) through an adjoining micropipette produced a rapid rise in current, reaching maximum amplitude in approximately 1.0 s and cleared by 80% within 4-11 s. Endogenously released ACh, following local depolarization with KCl (70 mm; 40, 160 nL), was detected at values as low as 0.05 microm. These signals were volume-dependent and cleared within 4-12 s. Finally, nicotine (1.0 mm, 80 nL) stimulated ACh signals. Nicotine-induced signals reflected the hydrolysis of ACh by endogenous acetylcholinesterase (AChE) as inhibition of the enzyme following perfusion with neostigmine (10 microm) attenuated the signal (40-94%). Collectively, these data validate a novel method for rapidly measuring cholinergic transmission in vivo with a spatial and temporal resolution that far exceeds conventional microdialysis.
Collapse
Affiliation(s)
- John P Bruno
- Department of Psychology, 57 Psychology Building, The Ohio State University, Columbus, OH 43210, USA.
| | | | | | | | | | | | | | | |
Collapse
|
123
|
Oldenziel WH, Dijkstra G, Cremers TIFH, Westerink BHC. In vivo monitoring of extracellular glutamate in the brain with a microsensor. Brain Res 2006; 1118:34-42. [PMID: 16956598 DOI: 10.1016/j.brainres.2006.08.015] [Citation(s) in RCA: 74] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2006] [Revised: 07/26/2006] [Accepted: 08/04/2006] [Indexed: 11/22/2022]
Abstract
Recent discoveries have revealed that glutamatergic neurotransmission in the central nervous system is mediated by a dynamic interplay between neurons and astrocytes. To enhance our understanding of this process, the study of extracellular glutamate is crucial. At present, microdialysis is the most frequently used analytical technique to monitor extracellular glutamate levels directly in the brain. However, the neuronal and physiological origin of the detected glutamate levels is questioned as they do not fulfil the classical release criteria for exocytotic release, such as calcium dependency or response to the sodium channel blocker tetrodotoxine (TTX). It is hypothesized that an analytical technique with a higher spatial and temporal resolution is required. Glutamate microsensors provide a promising analytical solution to meet this requirement. In the present study, we applied a 10 micro m diameter hydrogel-coated glutamate microsensor to monitor extracellular glutamate levels in the striatum of anesthetized rats. To explore the potential of the microsensor, different pharmacological agents were injected in the vicinity of the sensor at an approximate distance of 100 micro m. It was observed that KCl, exogenous glutamate, kainate and the reuptake inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) increased the extracellular glutamate levels significantly. TTX decreased the basal extracellular glutamate levels approximately 90%, which indicates that the microsensor is capable of detecting neuronally derived glutamate. This is one of the first studies in which a microsensor is applied in vivo on a routine base, and it is concluded that microsensor research can contribute significantly to improve our understanding of the physiology of glutamatergic neurotransmission in the brain.
Collapse
Affiliation(s)
- W H Oldenziel
- Department of Biomonitoring and Sensoring, University Center for Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
| | | | | | | |
Collapse
|
124
|
Nickell J, Salvatore MF, Pomerleau F, Apparsundaram S, Gerhardt GA. Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol Aging 2006; 28:1737-48. [PMID: 16959378 DOI: 10.1016/j.neurobiolaging.2006.07.015] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2006] [Revised: 06/30/2006] [Accepted: 07/17/2006] [Indexed: 10/24/2022]
Abstract
Extracellular L-glutamate poses a severe excitotoxic threat to neurons and glia when unregulated, therefore low synaptic levels of this neurotransmitter must be maintained via a rapid and robust transport system. A recent study from our laboratory showed a reduced glutamate uptake rate in the striatum of the aged Fischer 344 (F344) rat, yet the mechanism underlying this phenomenon is unknown. The current study utilized in vivo electrochemical recordings, immunoblotting and biotinylation in young (6 months), late-middle aged (18 months) and aged (24 months) F344 rats to elucidate the potential role that glutamate transporters (GLT-1, GLAST, and EAAC1) may play in this mechanism. Here we show that the time necessary to clear glutamate from the late-middle aged and aged striatum is significantly prolonged in comparison to the young striatum. In addition, an analysis of various sub-regions of the striatum revealed a marked dorsoventral gradient in terms of glutamate clearance times in the aged striatum, a phenomenon which was not present in the striatum of the animals of the remaining age groups. We also found that the decreased glutamate clearance time observed in the late-middle aged and aged rats is not due to a decrease in the production of total transporter protein among these three transporters. Rather, a significant reduction in the amount of GLAST expressed on the plasma membrane surface in the aged animals (approximately 55% when compared to young rats) may contribute to this phenomenon. These age-related alterations in extracellular l-glutamate regulation may be key contributors to the increased susceptibility of the aged brain to excitotoxic insults such as stroke and hypoxia.
Collapse
Affiliation(s)
- Justin Nickell
- Department of Anatomy and Neurobiology, Center for Sensor Technology, University of Kentucky Chandler Medical Center, Lexington, KY 40536-0098, USA.
| | | | | | | | | |
Collapse
|
125
|
Isik S, Castillo J, Blöchl A, Csöregi E, Schuhmann W. Simultaneous detection of L-glutamate and nitric oxide from adherently growing cells at known distance using disk shaped dual electrodes. Bioelectrochemistry 2006; 70:173-9. [PMID: 16733097 DOI: 10.1016/j.bioelechem.2006.03.037] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2005] [Indexed: 01/08/2023]
Abstract
An ex vivo system for simultaneous detection of nitric oxide (NO) and L-glutamate using integrated dual 250 microm platinum disk electrodes modified individually with suitable sensing chemistries has been developed. One of the sensors was coated with an electrocatalytic layer of Ni tetrasulfonate phthalocyanine tetrasodium salt (Ni-TSPc) covered by second layer of Nafion, which stabilises on the one hand the primary oxidation product NO(+) and prevents interferences from negatively charged compounds such as NO(2)(-). For glutamate determination, the second electrode was modified with a crosslinked redox hydrogel consisting of Os complex modified poly(vinylimidazol), glutamate oxidase and peroxidase. A manual x-y-z micromanipulator on top of an inverted optical microscope was used to position the dual electrode sensor at a defined distance of 5 microm from a cell population under visual control. C6 glioma cells were stimulated simultaneously with bradykinin or VEGF to release NO while KCl was used to invoke glutamate release. For evaluation of the glutamate sensors, in some experiments HN10 cells were used. To investigate the sensitivity and reliability of the system, several drugs were applied to the cells, e.g. Ca(2+)-channel inhibitors for testing Ca(2+)-dependence of the release of NO and glutamate, rotenone for inducing oxidative stress and glutamate antagonists for analysing glutamate release. With these drugs the NO and glutamate release was modulated in a similar way then expected from previously described systems or even in-vivo measurements. We therefore conclude that our system is suitable to analyse stress-induced mechanisms in cell lines.
Collapse
Affiliation(s)
- Sonnur Isik
- Anal. Chem.-Elektroanalytik and Sensorik, Universitätsstr. 150, D-44780 Bochum, Germany
| | | | | | | | | |
Collapse
|
126
|
Kitzmiller J, Beversdorf D, Hansford D. Fabrication and testing of microelectrodes for small-field cortical surface recordings. Biomed Microdevices 2006; 8:81-5. [PMID: 16491335 DOI: 10.1007/s10544-006-6386-6] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
A microfabrication approach to produce a microelectrode array that is suitable for use with human patients has been developed. The device is comprised of materials that are consistent with those of clinically used macroelectrodes (platinum electrode contacts suspended within a biomedical grade polydimethylsiloxane, PDMS). Photolithography, metal deposition, wire bonding, and PDMS encapsulation were used to fabricate the device. Cytotoxicity testing with both mammalian and human cortical cells suggests that the device is suitable for use with human patients and implementation of the device in animal studies revealed that reliable evoked potentials could be acquired with the designed spatial resolution.
Collapse
|
127
|
Oldenziel WH, de Jong LAA, Dijkstra G, Cremers TIFH, Westerink BHC. Improving the Performance of Glutamate Microsensors by Purification of Ascorbate Oxidase. Anal Chem 2006; 78:2456-60. [PMID: 16579635 DOI: 10.1021/ac051958l] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Enzyme-based biosensors have the potential to directly detect extracellular concentrations of glutamate in brain tissue with a high spatial and temporal resolution. To optimize their analytical performance, much attention has been paid to the architectural construction of these biosensors. In particular, the coupling of enzymes to the electrode surface has received much interest, which has resulted in many (derivatives of) first-, second-, and third-generation type of biosensors. However, it is remarkable that in the literature little attention, if any, has been paid to the influence of the quality of the enzyme itself on the analytical performance of a biosensor. Previously we have reported that different batches of ascorbate oxidase significantly altered the performance of our glutamate microsensor.(1) In this note, it is shown that a simple enzyme purification procedure as buffer exchange leads to a more uniform enzyme quality and also significantly improves the reproducibility and performance of the microsensor. In our opinion, this is an important observation and of general interest for the construction of enzyme-based biosensors.
Collapse
Affiliation(s)
- Weite H Oldenziel
- Department of Biomonitoring and Sensoring, University Center for Pharmacy, Groningen, The Netherlands.
| | | | | | | | | |
Collapse
|
128
|
Day BK, Pomerleau F, Burmeister JJ, Huettl P, Gerhardt GA. Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J Neurochem 2006; 96:1626-35. [PMID: 16441510 DOI: 10.1111/j.1471-4159.2006.03673.x] [Citation(s) in RCA: 144] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
L-glutamate (Glu) is the predominant excitatory neurotransmitter in the mammalian central nervous system. It plays major roles in normal neurophysiology and many brain disorders by binding to membrane-bound Glu receptors. To overcome the spatial and temporal limitations encountered in previous in vivo extracellular Glu studies, we employed enzyme-coated microelectrode arrays to measure both basal and potassium-evoked release of Glu in the anesthetized rat brain. We also addressed the question of signal identity, which is the predominant criticism of these recording technologies. In vivo self-referencing recordings demonstrated that our Glu signals were both enzyme- and voltage-dependent, supporting the identity of L-glutamate. In addition, basal Glu was actively regulated, tetrodotoxin (TTX)-dependent, and measured in the low micromolar range (approximately 2 microm) using multiple self-referencing subtraction approaches for identification of Glu. Moreover, potassium-evoked Glu release exhibited fast kinetics that were concentration-dependent and reproducible. These data support the hypothesis that Glu release is highly regulated, requiring detection technologies that must be very close to the synapse and measure on a second-by-second basis to best characterize the dynamics of the Glu system.
Collapse
Affiliation(s)
- B K Day
- Center For Sensor Technology, Morris K. Udall Parkinson's Disease Research Center of Excellence, Department of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky 40536-0098, USA
| | | | | | | | | |
Collapse
|
129
|
Fillenz M. In vivo neurochemical monitoring and the study of behaviour. Neurosci Biobehav Rev 2005; 29:949-62. [PMID: 15963566 DOI: 10.1016/j.neubiorev.2005.02.003] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2004] [Revised: 02/03/2005] [Accepted: 02/03/2005] [Indexed: 12/31/2022]
Abstract
In vivo neurochemical monitoring techniques measure changes in the extracellular compartment of selected brain regions. These changes reflect the release of chemical messengers and intermediates of brain energy metabolism resulting from the activity of neuronal assemblies. The two principal techniques used in neurochemical monitoring are microdialysis and voltammetry. The presence of glutamate in the extracellular compartment and its pharmacological characteristics suggest that it is released from astrocytes and acts as neuromodulator rather than a neurotransmitter. The changes in extracellular noradrenaline and dopamine reflect their role in the control of behaviour. Changes in glucose and oxygen, the latter a measure of local cerebral blood flow, reflect synaptic processing in the underlying neuronal networks rather than a measure of efferent output from the brain region. In vivo neurochemical monitoring provides information about the intermediate processing that intervenes between the application of the stimulus and the resulting behaviour but does not reflect the final efferent output that leads to behaviour.
Collapse
Affiliation(s)
- Marianne Fillenz
- University Laboratory of Physiology, Parks Road, Oxford OX1 3PT, UK.
| |
Collapse
|
130
|
Dale N, Hatz S, Tian F, Llaudet E. Listening to the brain: microelectrode biosensors for neurochemicals. Trends Biotechnol 2005; 23:420-8. [PMID: 15950302 DOI: 10.1016/j.tibtech.2005.05.010] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2005] [Revised: 04/19/2005] [Accepted: 05/24/2005] [Indexed: 10/25/2022]
Abstract
Chemical signalling underlies every function of the nervous system, from those of which we are unaware, for example, control of the heart, to higher cognitive functions, such as emotions, learning and memory. Neurotransmitters and neuromodulators mediate communication between neurons and between neurons and non-neural cells such as glia and muscle. In the past, the means for studying the production and release of these signalling agents directly has been limited in its temporal and spatial resolution relative to the dynamics of chemical signalling and the structures of interest in the brain. Now microelectrode biosensors are becoming available that give unprecedented spatial and temporal resolution, enabling, for the first time, direct measurement in real time of the chemical conversations between cells in the nervous system.
Collapse
Affiliation(s)
- Nicholas Dale
- Warwick Biosensors Group, Department of Biological Sciences, The University of Warwick, Coventry, CV4 7AL, UK.
| | | | | | | |
Collapse
|
131
|
Oldenziel WH, Westerink BHC. Improving Glutamate Microsensors by Optimizing the Composition of the Redox Hydrogel. Anal Chem 2005; 77:5520-8. [PMID: 16131061 DOI: 10.1021/ac0580013] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Amperometric hydrogel-coated glutamate microsensors form a promising concept to detect glutamate levels directly in brain tissue. These microsensors are constructed by coating a carbon fiber electrode (CFE) (10 microm diameter; 300-500 microm long) with a five-component redox-hydrogel, in which L-glutamate oxidase, horseradish peroxidase, and ascorbate oxidase are wired via poly(ethylene glycol) diglycidyl ether to an osmium-containing redox polymer. Coating with a thin Nafion film completes the construction. Prior to use in vivo, a reliable and reproducible construction of microsensors with a high performance is required. For an optimal microsensor performance, the balance between the five individual hydrogel components is critical. However, due to their small size, hydrogel application to CFE's need to be performed by dip-coating. Dip-coating is a difficult procedure to control and does not allow individual application of hydrogel constituents. To improve the microsensor construction and to better control the dip-coating procedure, we have recently developed an automated device. Throughout this study, automatic dip-coating was performed with premixed solutions, in which the amount of a single component was varied. This allowed us to optimize the hydrogel composition, which resulted in a significant improvement of the microsensor properties in terms of sensitivity, current density, linearity, detection limit, and interference by ascorbic acid.
Collapse
Affiliation(s)
- Weite H Oldenziel
- Department of Biomonitoring and Sensoring, University Center for Pharmacy, Groningen, The Netherlands.
| | | |
Collapse
|
132
|
Liaw WJ, Stephens RL, Binns BC, Chu Y, Sepkuty JP, Johns RA, Rothstein JD, Tao YX. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005; 115:60-70. [PMID: 15836970 DOI: 10.1016/j.pain.2005.02.006] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2004] [Revised: 01/19/2005] [Accepted: 02/07/2005] [Indexed: 10/25/2022]
Abstract
Glutamate is a major excitatory neurotransmitter in primary afferent terminals and is critical for normal spinal excitatory synaptic transmission. However, little is known about the regulation of synaptically released glutamate in the spinal cord under physiologic conditions. The sodium-dependent, high-affinity glutamate transporters are the primary mechanism for the clearance of synaptically released glutamate. In the present study, we found that intrathecal injection of glutamate transporter blockers DL-threo-beta-benzyloxyaspartate (TBOA) and dihydrokainate produced significant and dose-dependent spontaneous nociceptive behaviors, such as licking, shaking, and caudally directed biting, phenomena similar to the behaviors caused by intrathecal glutamate receptor agonists. Intrathecal TBOA also led to remarkable hypersensitivity in response to thermal and mechanical stimuli. These behavioral responses could be significantly blocked by intrathecal injection of the NMDA receptor antagonists MK-801 and AP-5, the non-NMDA receptor antagonist CNQX or the nitric oxide synthase inhibitor L-NAME. In vivo microdialysis analysis showed short-term elevation of extracellular glutamate concentration in the spinal cord after intrathecal injection of TBOA. Furthermore, topical application of TBOA on the dorsal surface of the spinal cord resulted in a significant elevation of extracellular glutamate concentration demonstrated by in vivo glutamate voltametry. The present study indicates that defective spinal glutamate uptake caused by inhibition of glutamate transporters leads to excessive glutamate accumulation in the spinal cord. The latter results in persistent over-activation of synaptic glutamate receptors, producing spontaneous nociceptive behaviors and sensory hypersensitivity. Our results suggest that glutamate uptake through spinal glutamate transporters is critical for maintaining normal sensory transmission under physiologic conditions.
Collapse
Affiliation(s)
- Wen-Jinn Liaw
- Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, 355 Ross, 720 Rutland Ave., Baltimore, MD 21205, USA
| | | | | | | | | | | | | | | |
Collapse
|
133
|
Abstract
Considerable evidence suggests that the synapse is the most sensitive CNS element for ethanol effects. Although most alcohol research has focussed on the postsynaptic sites of ethanol action, especially regarding interactions with the glutamatergic and GABAergic receptors, few such studies have directly addressed the possible presynaptic loci of ethanol action, and even fewer describe effects on synaptic terminals. Nonetheless, there is burgeoning evidence that presynaptic terminals play a major role in ethanol effects. The methods used to verify such ethanol actions range from electrophysiological analysis of paired-pulse facilitation (PPF) and spontaneous and miniature synaptic potentials to direct recording of ion channel activity and transmitter/messenger release from acutely isolated synaptic terminals, and microscopic observation of vesicular release, with a focus predominantly on GABAergic, glutamatergic, and peptidergic synapses. The combined data suggest that acute ethanol administration can both increase and decrease the release of these transmitters from synaptic terminals, and more recent results suggest that prolonged or chronic ethanol treatment (CET) can also alter the function of presynaptic terminals. These new findings suggest that future analyses of synaptic effects of ethanol should attempt to ascertain the role of presynaptic terminals and their involvement in alcohol's behavioral actions. Other future directions should include an assessment of ethanol's effects on presynaptic signal transduction linkages and on the molecular machinery of transmitter release and exocytosis in general. Such studies could lead to the formulation of new treatment strategies for alcohol intoxication, alcohol abuse, and alcoholism.
Collapse
Affiliation(s)
- George Robert Siggins
- Department of Neuropharmacology and Alcohol Research Center, The Scripps Research Institute, CVN-12, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
| | | | | |
Collapse
|
134
|
Drew KL, Pehek EA, Rasley BT, Ma YL, Green TK. Sampling glutamate and GABA with microdialysis: suggestions on how to get the dialysis membrane closer to the synapse. J Neurosci Methods 2005; 140:127-31. [PMID: 15589342 DOI: 10.1016/j.jneumeth.2004.04.039] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2003] [Revised: 04/14/2004] [Accepted: 04/24/2004] [Indexed: 11/17/2022]
Abstract
Microdialysis is currently optimized to sample the extrasynaptic pool. As such, the technique has facilitated discovery of ischemia-induced excitotoxic glutamate overflow (Benveniste H, Drejer J, Schousboe A, Diemer NH, 1987, Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J. Neurochem., 49, 729-734) and adenosinergic sleep drive (Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW, 1997, Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science, 276 (5316), 1265-1268); and is proving essential for clinical monitoring of glutamate and cellular metabolites in stroke and head trauma (Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit. Care Med. 2002, 30 (5): 1062-1070). Study of the origin of extrasynaptic glutamate sampled with microdialysis has advanced understanding of extrasynaptic signal processing (Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 2002, 22 (20): 9134-9141; Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW, 2003, Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat. Neurosci., 6, 743-749) in the CNS. Microdialysis studies furthermore demonstrate that synaptic pools of some neurotransmitters spill into the extrasynaptic space. For this reason, microdialysis has provided a window into the synaptic pool that has significantly advanced understanding of neurotransmitter control of behavior (Tanda G, Pontieri FE, Di Chiara G, 1997, Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science, 276, 2048-2050). Nonetheless, ability to sample synaptic pools of neurotransmitters is limited. Here we summarize evidence that microdialysis often fails to sample synaptic pools of neurotransmitters, such as glutamate and GABA because of rapid clearance and limited diffusion of these neurotransmitters from the synapse. Moreover, we consider means to move the dialysis membrane closer to the synapse to facilitate sampling of the synaptic pool of these neurotransmitters by minimizing tissue trauma, decreasing probe size and increasing temporal resolution.
Collapse
Affiliation(s)
- K L Drew
- Department of Chemistry and Biochemistry and Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, PO Box 757000, AK 99775-7000, USA.
| | | | | | | | | |
Collapse
|
135
|
Binns BC, Huang Y, Goettl VM, Hackshaw KV, Stephens RL. Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model. Brain Res 2005; 1041:38-47. [PMID: 15804498 DOI: 10.1016/j.brainres.2005.01.088] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2004] [Revised: 01/25/2005] [Accepted: 01/26/2005] [Indexed: 11/25/2022]
Abstract
Alteration of glutamatergic (GLU) neurotransmission within the spinal cord contributes to hyperalgesic and allodynic responses following nerve injury. In particular, changes in expression and efficacy of glutamate transporters have been reported. Excitatory, pain transmitting primary afferent neurons utilizing glutamate as an excitatory neurotransmitter project to both superficial (I-II) and deep (III-V) laminae of the dorsal horn. These experiments were designed to examine changes in glutamate uptake occurring concomitantly within the spinal deep dorsal and ventral horn in situ after experimentally induced neuropathic pain. In vivo voltammetry, using microelectrode arrays configured for enzyme-based detection of GLU were employed. Sprague-Dawley rats had either sham surgery or tight ligation of L5 and L6 spinal nerves (SNL). Four to six weeks later, the L4-L6 spinal cord of chloral hydrate-anesthetized animals was exposed, and ceramic-based glutamate microelectrodes equipped with glass micropipettes 50 microm from the recording surfaces were placed stereotaxically at sites within the spinal cord. Pressure ejection of GLU into the ipsilateral L5-L6 spinal cord resulted in a 72% reduction of GLU uptake in SNL rats compared to sham controls in the ipsilateral L5-L6 deep dorsal horn and a 96% reduction in the ventral horn. In contrast, in the same animals, the contralateral L5-L6 or the ipsilateral L4 spinal cord showed no change in glutamate uptake. The data suggest that spinal nerve ligation produced attenuated glutamate uptake activity extending into the deep dorsal and ventral horn. The study suggests that plasticity related to spinal nerve injury produces widespread alteration in glutamate transporter function that may contribute to the pathophysiology of neuropathic pain.
Collapse
Affiliation(s)
- Brian C Binns
- Department of Physiology and Cell Biology, 304 Hamilton Hall, 1645 Neil Avenue, The Ohio State University, Columbus, OH 43210, USA
| | | | | | | | | |
Collapse
|
136
|
Castillo J, Blöchl A, Dennison S, Schuhmann W, Csöregi E. Glutamate detection from nerve cells using a planar electrodes array integrated in a microtiter plate. Biosens Bioelectron 2005; 20:2116-9. [PMID: 15741083 DOI: 10.1016/j.bios.2004.09.013] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2004] [Revised: 09/20/2004] [Accepted: 09/20/2004] [Indexed: 11/16/2022]
Abstract
There is an increasing interest in new strategies for replacing animal tests in research. The use of cell cultures and integrated electrodes is seen as a promising alternative that could potentially solve this problem. In this work, we present a L-glutamate sensor based on a bienzyme redox hydrogel, capable of detecting the release of this excitatory neurotransmitter from adherently growing cells upon stimulation. The low working potential required for the operation of the sensor decreases the possibility of interference by easily oxidizable compounds always present in complex biological samples. A low detection limit of 0.5 microM L-glutamate, a response time of about 35 s, and a linear range of up to 60 microM are the main characteristics of the sensor. The system has been successfully employed to monitor the release of l-glutamate from HN10 and C6 cells upon stimulation with K(+)-ions. The developed integrated electrochemical platform will be used in future for drug screening and potentially for replacing animal models in neurological experiments.
Collapse
|
137
|
Burmeister JJ, Palmer M, Gerhardt GA. l-lactate measures in brain tissue with ceramic-based multisite microelectrodes. Biosens Bioelectron 2005; 20:1772-9. [PMID: 15681193 DOI: 10.1016/j.bios.2004.07.003] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2004] [Revised: 07/02/2004] [Accepted: 07/07/2004] [Indexed: 11/30/2022]
Abstract
A newly developed multisite array microelectrode for in vivo measurements of L-lactate is presented. The resulting microelectrode is composed of three functional layers. First, Nafion is used to repel interfering electroactive anions, such as ascorbate. Second, L-lactate oxidase immobilized onto the recording sites is used to convert L-lactate to hydrogen peroxide. The H2O2 produced is proportional to L-lactate concentrations and is quantified at the platinum recording sites. Third, a layer of polyurethane is coated over the L-lactate oxidase to adjust the linear range of the microelectrode to one that is compatible with in vivo measurements. This layer reduces the amount of L-lactate that diffuses to the enzyme while not significantly limiting oxygen diffusion. The resulting L-lactate microelectrodes were linear to 20 mM (R2 = 0.997 +/- 0.001) and beyond in some cases with detection limits of 0.078 +/- 0.013 mM (n = 12). The selectivity and response time of these electrodes make them suitable for in vivo measurements in brain tissue. Self-referencing recordings may be utilized to further improve the selectivity of the recordings. However this is not necessary for most applications in the brain, because the resting and stimulated levels of dopamine (DA), norepinephrine (NE), and other potentially interfering cations are two to three orders of magnitude lower than that of in vivo L-lactate, which is in the millimolar range. Preliminary in vivo measures of L-lactate in the brain of anesthetized rats support that the microelectrodes are capable of measuring rapid endogenous changes in vivo.
Collapse
Affiliation(s)
- Jason J Burmeister
- Department of Anatomy, Center for Sensor Technology, The Morris K. Udall Parkinson's Disease Research Center of Excellence, University of Kentucky Chandler Medical Center, Room 306 Davis Mills Building, Lexington, KY 40536-0098, USA
| | | | | |
Collapse
|
138
|
McMahon CP, O'Neill RD. Polymer−Enzyme Composite Biosensor with High Glutamate Sensitivity and Low Oxygen Dependence. Anal Chem 2005; 77:1196-9. [PMID: 15859007 DOI: 10.1021/ac048686r] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
139
|
O'Neill RD, Chang SC, Lowry JP, McNeil CJ. Comparisons of platinum, gold, palladium and glassy carbon as electrode materials in the design of biosensors for glutamate. Biosens Bioelectron 2004; 19:1521-8. [PMID: 15093225 DOI: 10.1016/j.bios.2003.12.004] [Citation(s) in RCA: 105] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2003] [Revised: 12/02/2003] [Accepted: 12/05/2003] [Indexed: 11/28/2022]
Abstract
Four electrode materials: Pt, Au, Pd and glassy carbon (GC), were studied to investigate their suitability as substrates in the development of two different classes of glutamate biosensor. Glutamate oxidase cross-linked onto poly(o-phenylenediamine) was chosen as the type 1 biosensor (PPD/GluOx), incorporating PPD as the permselective element to detect H(2)O(2) directly on the electrode surface at relatively high applied potentials. GluOx and horseradish peroxidase/redox polymer modified electrodes (Os(2+)PVP/HRP/GluOx) that relied on enzyme-catalysed H(2)O(2) detection at lower applied potentials were used as type 2 biosensors. The voltammetric and amperometric responses to the enzyme signal transduction molecule, H(2)O(2), and the archetypal interference species in biological applications, ascorbic acid, were determined on the bare and PPD/GluOx-modified surfaces. The amperometric responses of these electrodes were stable over several days of continuous recording in phosphate buffered saline (pH 7.4). The sensitivity of the type 1 biosensors to H(2)O(2) and glutamate showed parallel trends with low limits of detection and good linearity at low concentrations: Pt>Au approximately Pd>>GC. Type 2 biosensors out-performed the type 1 design for all electrode substrates, except Pt. However, the presence of the permselective PPD membrane in the type 1 biosensors, not feasible in the type 2 design, suggests that Pt/PPD/GluOx might have the best all-round characteristics for glutamate detection in biological media containing interference species such as ascorbic acid. Other points affecting a final choice of substrate should include factors such as mass production issues.
Collapse
Affiliation(s)
- Robert D O'Neill
- Department of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland.
| | | | | | | |
Collapse
|
140
|
Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP. Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci 2004; 20:1545-54. [PMID: 15355321 DOI: 10.1111/j.1460-9568.2004.03614.x] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Conventional microdialysis methods for measuring acetylcholine (ACh) efflux do not provide sufficient temporal resolution to relate cholinergic transmission to individual stimuli or behavioral responses, or sufficient spatial resolution to investigate heterogeneities in such regulation within a brain region. In an effort to overcome these constraints, we investigated a ceramic-based microelectrode array designed to measure amperometrically rapid changes in extracellular choline as a marker for cholinergic transmission in the frontoparietal cortex of anesthetized rats. These microelectrodes exhibited detection limits of 300 nm for choline and selectivity (> 100 : 1) of choline over interferents such as ascorbic acid. Intracortical pressure ejections of choline (20 mm, 66-400 nL) and ACh (10 and 100 mm, 200 nL) dose-dependently increased choline-related signals that were cleared to background levels within 10 s. ACh, but not choline-induced signals, were significantly attenuated by co-ejection of the acetylcholinesterase inhibitor neostigmine (Neo; 100 mm). Pressure ejections of drugs known to increase cortical ACh efflux, potassium (KCl; 70 mm, 66, 200 nL) and scopolamine (Scop; 10 mm, 200 nL), also markedly increased extracellular choline signals, which again were inhibited by Neo. Scop-induced choline signals were also found to be tetrodotoxin-sensitive. Collectively, these findings suggest that drug-induced increases in current measured with these microelectrode arrays reflect the oxidation of choline that is neuronally derived from the release and subsequent hydrolysis of ACh. Choline signals assessed using enzyme-selective microelectrode arrays may represent a rapid, sensitive and spatially discrete measure of cholinergic transmission.
Collapse
Affiliation(s)
- Vinay Parikh
- Psychobiology and Behavioural Neuroscience, Department of Psychology, Ohio State University, Columbus, OH, USA
| | | | | | | | | | | |
Collapse
|
141
|
Oldenziel WH, Beukema W, Westerink BHC. Improving the reproducibility of hydrogel-coated glutamate microsensors by using an automated dipcoater. J Neurosci Methods 2004; 140:117-26. [PMID: 15589341 DOI: 10.1016/j.jneumeth.2004.04.038] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2003] [Accepted: 04/06/2004] [Indexed: 11/17/2022]
Abstract
Hydrogel-coated microsensors based on carbon fiber electrodes (CFEs) are promising tools for in vivo analysis of endogeneous compounds such as glutamate. However, their construction generally depends on manual fabrication, which often results in poor reproducibility. The aim of this study was to improve the reproducibility and performance of glutamate microsensors. CFEs (10 microm diameter, 300-500 microm long) were coated with a cross-linked redox-polymer hydrogel containing l-glutamate oxidase, horseradish peroxidase and ascorbate oxidase. Various parameters that are likely to influence the reproducibility of the glutamate microsensors were studied. It appeared that the most crucial step in determining the microsensor performance is the manual hydrogel-application procedure. To control this procedure an automated dipcoater was constructed, which allowed mechanical application of the hydrogel on the CFE under standardized conditions. Significant improvements in performance were seen when the CFEs were dipcoated for 10 min at 37 degrees C. Further improvements were obtained when the automated hydrogel application was combined with other cross-link methods, such as electrodeposition and electrostatic complexation. A crucial factor in determining the microsensor performance is the hydrogel thickness. Microscopic observations revealed that, despite the use of an automated dipcoater, the layer thickness was not constant. By combining the automated dipcoat technique with amperometry, the layer thickness could be indirectly monitored and controlled, which resulted in significant improvements of the reproducibility of the sensors.
Collapse
Affiliation(s)
- W H Oldenziel
- Department of Biomonitoring and Sensoring, University Center for Pharmacy, 9713 AV Groningen, The Netherlands.
| | | | | |
Collapse
|
142
|
Shou M, Smith AD, Shackman JG, Peris J, Kennedy RT. In vivo monitoring of amino acids by microdialysis sampling with on-line derivatization by naphthalene-2,3-dicarboxyaldehyde and rapid micellar electrokinetic capillary chromatography. J Neurosci Methods 2004; 138:189-97. [PMID: 15325127 DOI: 10.1016/j.jneumeth.2004.04.006] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2003] [Revised: 03/16/2004] [Accepted: 04/01/2004] [Indexed: 12/21/2022]
Abstract
An analytical method was developed to monitor amino acids collected by in vivo microdialysis. Microdialysate was continuously derivatized on-line by mixing 6 mM naphthalene-2,3-dicarboxyaldehyde (NDA) and 10 mM potassium cyanide with the dialysate stream in a fused silica capillary to form fluorescent products. Reaction time, determined by the flow rate and volume of reaction capillary, was 3 min. Derivatized amino acids were continuously delivered into a flow-gated interface and periodically injected onto a capillary electrophoresis unit equipped with a laser-induced fluorescence detection based on a commercial microscope. Separation was performed in the micellar electrokinetic chromatography mode using 30 mM sodium dodecyl sulfate in 15 mM phosphate buffer at pH 8.0 as the separation media. An electric field of 1.3 kV/cm was applied across a 10 cm long, 10 microm internal diameter separation capillary. These conditions allowed 17 amino acid derivatives to be resolved in less than 30 s. On-line injections could be performed at 30 s intervals for in vivo samples. Detection limits were from 10 to 30 nM for the amino acids. The method was applied to monitor the acute ethanol-induced amino acid level changes in freely moving rats. The results demonstrate the utility of the method to reveal dynamics of amino acid concentration in vivo.
Collapse
Affiliation(s)
- Minshan Shou
- Department of Chemistry, University of Michigan, 930 North University Avenue, Ann Arbor, MI 48109, USA
| | | | | | | | | |
Collapse
|
143
|
Peters JL, Miner LH, Michael AC, Sesack SR. Ultrastructure at carbon fiber microelectrode implantation sites after acute voltammetric measurements in the striatum of anesthetized rats. J Neurosci Methods 2004; 137:9-23. [PMID: 15196823 DOI: 10.1016/j.jneumeth.2004.02.006] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2003] [Revised: 01/20/2004] [Accepted: 02/03/2004] [Indexed: 12/31/2022]
Abstract
This work seeks to establish the feasibility of characterizing the ultrastructure of brain tissue disruption associated with the implantation of carbon fiber voltammetric microelectrodes. In vivo recording was performed by fast scan cyclic voltammetry in conjunction with carbon fiber microelectrodes (3.5 microm radius) in the striatum of rats anesthetized with chloral hydrate. After 4 h of in vivo recording, the microelectrodes were removed from the brain and the animals underwent intracardial perfusion. Brain tissue was collected and sectioned in the horizontal plane perpendicular to the axis of the microelectrodes. With microelectrodes of a conventional single barreled design, the tissue tracks were often too small to be followed by light microscopy to the point of deepest penetration, which would correspond to the implantation site of the carbon fiber itself. The enlarged tissue tracks formed by the implantation of double barreled electrodes, however, could be followed to their termination by light microscopy. Anatomical mapping was used to identify the fields laying 100 microm deeper than the deepest trace of such tracks. Electron microscopy of these fields revealed a spot of tissue damage presumed to be associated with the implantation site of the carbon fiber microelectrode. The spot of maximal tissue damage had a radius of 2.5 microm and was surrounded by an annular region with a width of 4 microm that contained a mix of healthy and damaged elements. Beyond this annular region, i.e. beyond 6.5 microm from the center of the spot of maximal damage, signs of microelectrode-associated damage were rare and consisted primarily of neurons with darkened cytoplasm.
Collapse
Affiliation(s)
- Jennifer L Peters
- Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA
| | | | | | | |
Collapse
|
144
|
Pomerleau F, Day BK, Huettl P, Burmeister JJ, Gerhardt GA. Real Timein VivoMeasures of l-Glutamate in the Rat Central Nervous System Using Ceramic-Based Multisite Microelectrode Arrays. Ann N Y Acad Sci 2003; 1003:454-7. [PMID: 14684487 DOI: 10.1196/annals.1300.051] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- F Pomerleau
- Center for Sensor Technology, University of Kentucky, Lexington, Kentucky 40536, USA.
| | | | | | | | | |
Collapse
|
145
|
|
146
|
Burmeister JJ, Gerhardt GA. Ceramic-based multisite microelectrode arrays for in vivo electrochemical recordings of glutamate and other neurochemicals. Trends Analyt Chem 2003. [DOI: 10.1016/s0165-9936(03)00904-x] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
147
|
Kulagina NV, Michael AC. Monitoring Hydrogen Peroxide in the Extracellular Space of the Brain with Amperometric Microsensors. Anal Chem 2003; 75:4875-81. [PMID: 14674466 DOI: 10.1021/ac034573g] [Citation(s) in RCA: 103] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Interest in the detection of hydrogen peroxide in living brain tissue is growing for several reasons. Peroxide and other reactive oxygen species are implicated in neurodegenerative disorders and appear to have neuromodulatory functions in the brain. Also, there is a need to measure peroxide levels as a companion to measurements with amperometric sensors that rely on enzymes to generate peroxide for the detection of glutamate, choline, and glucose. Herein, we report on measurements performed in the brain of anesthetized rats with carbon fiber amperometric sensors coated with a cross-linked redox polymer film that contains horseradish peroxidase. Prior work with these sensors has established that they are both sensitive and selective toward hydrogen peroxide. When implanted in the striatal region of the rat brain, a biphasic response is observed upon electrical stimulation of the dopaminergic pathway that innervates the striatal tissue. No response is observed at sensors lacking HRP, which are not sensitive to peroxide, suggesting that the biphasic response is due to the production of hydrogen peroxide by two separate mechanisms. Additional measurements of dopamine and oxygen, and the administration of two drugs with well-known effects on the biochemical kinetics of the dopamine neurons, are used to identify those mechanisms. One appears to be the production of peroxide upon the oxidation of dopamine by molecular oxygen. This occurs during the electrical stimulation itself, which elevates both dopamine and oxygen levels in the extracellular space. The other appears to be the production of peroxide as a byproduct in the oxidative metabolic conversion of dopamine to DOPAC by the mitochondrial enzyme, monoamine oxidase. The production of peroxide due to dopamine metabolism is also observed after rats receive a dose of L-DOPA, a drug used in the treatment of Parkinson's disease.
Collapse
Affiliation(s)
- Nadezhda V Kulagina
- Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | | |
Collapse
|
148
|
Burmeister JJ, Palmer M, Gerhardt GA. Ceramic-based multisite microelectrode array for rapid choline measures in brain tissue. Anal Chim Acta 2003. [DOI: 10.1016/s0003-2670(03)00067-9] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|